Abbott To Acquire Bigfoot Biomedical, Furthering Efforts To Develop Personalized, Connected Solutions For People With Diabetes
Sep 05, 2023•almost 2 years ago
Acquiring Company
Abbott
Acquired Company
Bigfoot Biomedical
Description
Abbott (NYSE: ABT) and Bigfoot Biomedical today announced a definitive agreement for Abbott to acquire Bigfoot, a leader in developing smart insulin management systems for people with diabetes.
DealWatch™ Score
73
High M&A Activity
M&A Opportunity Analysis
Get personalized insights on M&A opportunities
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed